| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BBAMCR.2015.02.023 |
| P8608 | Fatcat ID | release_qer7oeqfj5a3tlub3s5mwpcuqq |
| P932 | PMC publication ID | 4380670 |
| P698 | PubMed publication ID | 25746720 |
| P5875 | ResearchGate publication ID | 273326905 |
| P2093 | author name string | Fei Gao | |
| Payaningal R Somanath | |||
| Ahmad Al-Azayzih | |||
| P2860 | cites work | Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3 | Q24550794 |
| The role of Snail in prostate cancer | Q27004557 | ||
| Epithelial-mesenchymal transitions in development and disease | Q27860630 | ||
| Mechanisms of TGF-beta signaling from cell membrane to the nucleus | Q27860785 | ||
| Cancer statistics, 2014 | Q27861018 | ||
| Cadherins and epithelial-to-mesenchymal transition | Q38088483 | ||
| TGFβ and matrix-regulated epithelial to mesenchymal transition | Q38190340 | ||
| P21 activated kinases: structure, regulation, and functions | Q38198494 | ||
| The metastasis suppressor NDRG1 modulates the phosphorylation and nuclear translocation of β-catenin through mechanisms involving FRAT1 and PAK4. | Q38994899 | ||
| TRAF4 promotes TGF-β receptor signaling and drives breast cancer metastasis | Q39105929 | ||
| An allosteric kinase inhibitor binds the p21-activated kinase autoregulatory domain covalently. | Q39805071 | ||
| Transforming growth factor beta1 induces apoptosis by suppressing FLICE-like inhibitory protein in DU145 prostate epithelial cells | Q39910058 | ||
| PAK1 regulates myosin II-B phosphorylation, filament assembly, localization and cell chemotaxis | Q40402760 | ||
| Mechanism of p21-activated Kinase 6-mediated Inhibition of Androgen Receptor Signaling | Q40624022 | ||
| Rac, PAK and p38 regulate cell contact-dependent nuclear translocation of myocardin-related transcription factor. | Q41286123 | ||
| Tumor measurement in the nude mouse | Q41355093 | ||
| Rac1/PAK1 signaling promotes epithelial-mesenchymal transition of podocytes in vitro via triggering β-catenin transcriptional activity under high glucose conditions | Q45072545 | ||
| Modulation of p21-activated kinase 1 alters the behavior of renal cell carcinoma | Q60549518 | ||
| Androgen receptor specifically interacts with a novel p21-activated kinase, PAK6 | Q28208123 | ||
| NEDD9 crucially regulates TGF-β-triggered epithelial-mesenchymal transition and cell invasion in prostate cancer cells: involvement in cancer progressiveness | Q28238097 | ||
| p21-Activated kinase 4 promotes prostate cancer progression through CREB | Q28269126 | ||
| PAK1 kinase promotes cell motility and invasiveness through CRK-II serine phosphorylation in non-small cell lung cancer cells | Q28272164 | ||
| TGFβ signalling in context | Q28275410 | ||
| A PAK4-LIMK1 pathway drives prostate cancer cell migration downstream of HGF | Q28277064 | ||
| P21 activated kinase-1 (Pak1) promotes prostate tumor growth and microinvasion via inhibition of transforming growth factor β expression and enhanced matrix metalloproteinase 9 secretion | Q28281866 | ||
| TGFbeta in Cancer | Q28288866 | ||
| PAK signalling during the development and progression of cancer | Q28307460 | ||
| Rac1 activation driven by 14-3-3ζ dimerization promotes prostate cancer cell-matrix interactions, motility and transendothelial migration | Q28481314 | ||
| FLICE-like inhibitory protein blocks transforming growth factor beta 1-induced caspase activation and apoptosis in prostate epithelial cells | Q28572067 | ||
| Cancer metastasis: building a framework | Q29616783 | ||
| Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle? | Q33351622 | ||
| Two faces of TGF-beta1 in breast cancer | Q33661529 | ||
| SMAD3 represses androgen receptor-mediated transcription | Q33940789 | ||
| TGFβ-induced invasion of prostate cancer cells is promoted by c-Jun-dependent transcriptional activation of Snail1 | Q34028544 | ||
| Clinically relevant doses of candesartan inhibit growth of prostate tumor xenografts in vivo through modulation of tumor angiogenesis | Q34125083 | ||
| DHT Selectively Reverses Smad3-Mediated/TGF-β-Induced Responses through Transcriptional Down-Regulation of Smad3 in Prostate Epithelial Cells | Q34197256 | ||
| TGF-beta signaling in cancer--a double-edged sword | Q34421804 | ||
| Non-Smad TGF-beta signals | Q34443708 | ||
| European cancer mortality predictions for the year 2014. | Q34661464 | ||
| PAK1 as a therapeutic target | Q35108164 | ||
| BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study | Q35299011 | ||
| TGFβ1 induces apoptosis in invasive prostate cancer and bladder cancer cells via Akt-independent, p38 MAPK and JNK/SAPK-mediated activation of caspases | Q36792632 | ||
| Vimentin and epithelial-mesenchymal transition in human breast cancer--observations in vitro and in vivo. | Q36857862 | ||
| Pak1 kinase links ErbB2 to β-catenin in transformation of breast epithelial cells | Q36941519 | ||
| PAK1 regulates breast cancer cell invasion through secretion of matrix metalloproteinases in response to prolactin and three-dimensional collagen IV. | Q36998060 | ||
| 14-3-3beta-Rac1-p21 activated kinase signaling regulates Akt1-mediated cytoskeletal organization, lamellipodia formation and fibronectin matrix assembly | Q37013219 | ||
| The relevance of the TGF-β Paradox to EMT-MET programs | Q37118399 | ||
| Tumor necrosis factor-receptor-associated factor-4 is a positive regulator of transforming growth factor-beta signaling that affects neural crest formation | Q37262166 | ||
| Dysfunctional transforming growth factor-beta receptor II accelerates prostate tumorigenesis in the TRAMP mouse model | Q37355355 | ||
| TGF-β: duality of function between tumor prevention and carcinogenesis. | Q37634488 | ||
| Switching TGFβ from a tumor suppressor to a tumor promoter. | Q37830876 | ||
| Non-Smad signaling pathways | Q37893980 | ||
| TGF-β signaling and epithelial-mesenchymal transition in cancer progression | Q38063807 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 1229-1239 | |
| P577 | publication date | 2015-03-06 | |
| P1433 | published in | Biochimica et Biophysica Acta | Q864239 |
| P1476 | title | P21 activated kinase-1 mediates transforming growth factor β1-induced prostate cancer cell epithelial to mesenchymal transition | |
| P478 | volume | 1853 |
| Q41637016 | Akt1 promotes stimuli-induced endothelial-barrier protection through FoxO-mediated tight-junction protein turnover |
| Q42086463 | Clinicopathological signature of p21-activated kinase 1 in prostate cancer and its regulation of proliferation and autophagy via the mTOR signaling pathway |
| Q89939464 | DEP Domain-Containing Protein 1B (DEPDC1B) Promotes Migration and Invasion in Pancreatic Cancer Through the Rac1/PAK1-LIMK1-Cofilin1 Signaling Pathway |
| Q36963000 | Diallyl disulfide suppresses epithelial-mesenchymal transition, invasion and proliferation by downregulation of LIMK1 in gastric cancer |
| Q90087899 | Effect of P21-activated kinase 1 (PAK-1) inhibition on cancer cell growth, migration, and invasion |
| Q47427215 | Ganoderma lucidum polysaccharide inhibits prostate cancer cell migration via the protein arginine methyltransferase 6 signaling pathway |
| Q52674354 | Glyoxalase 1 sustains the metastatic phenotype of prostate cancer cells via EMT control. |
| Q88947003 | Isoform-specific effects of transforming growth factor β on endothelial-to-mesenchymal transition |
| Q36957793 | Liposome-mediated delivery of the p21 activated kinase-1 (PAK-1) inhibitor IPA-3 limits prostate tumor growth in vivo |
| Q64119982 | MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2 |
| Q38810246 | MicroRNA-663 suppresses cell invasion and migration by targeting transforming growth factor beta 1 in papillary thyroid carcinoma |
| Q58732411 | Modulation in the microRNA repertoire is responsible for the stage-specific effects of Akt suppression on murine neuroendocrine prostate cancer |
| Q99630289 | P21-Activated Kinase 1: Emerging biological functions and potential therapeutic targets in Cancer |
| Q28551296 | P21-Activated Kinase Inhibitors FRAX486 and IPA3: Inhibition of Prostate Stromal Cell Growth and Effects on Smooth Muscle Contraction in the Human Prostate |
| Q91886070 | PAK1 promotes proliferation, migration and invasion of hepatocellular carcinoma by facilitating EMT via directly up-regulating Snail |
| Q36031247 | Potential role of p21 Activated Kinase 1 (PAK1) in the invasion and motility of oral cancer cells |
| Q52622319 | Regulating Cdc42 and Its Signaling Pathways in Cancer: Small Molecules and MicroRNA as New Treatment Candidates. |
| Q99551806 | Sterically stabilized liposomes targeting P21 (RAC1) activated kinase-1 and secreted phospholipase A2 suppress prostate cancer growth and metastasis |
| Q50590583 | Suppression of Akt1-β-catenin pathway in advanced prostate cancer promotes TGFβ1-mediated epithelial to mesenchymal transition and metastasis. |
| Q38904873 | Synergistic immunologic targets for the treatment of prostate cancer |
| Q48199906 | TRAF6 regulates tumour metastasis through EMT and CSC phenotypes in head and neck squamous cell carcinoma. |
| Q64054193 | Targeting p21-activated kinase 1 inhibits growth and metastasis via Raf1/MEK1/ERK signaling in esophageal squamous cell carcinoma cells |
| Q50082534 | The concomitant apoptosis and EMT underlie the fundamental functions of TGF-β. |
| Q54977610 | The p21-activated kinase 4-Slug transcription factor axis promotes epithelial-mesenchymal transition and worsens prognosis in prostate cancer. |
| Q38846822 | The role of small GTPases of the Rho/Rac family in TGF-β-induced EMT and cell motility in cancer |
| Q57810885 | Unfractionated and Low Molecular Weight Heparin Reduce Platelet Induced Epithelial-Mesenchymal Transition in Pancreatic and Prostate Cancer Cells |
Search more.